Sign inJoin waitlistJoin the waitlist

Franco Felizarta

Faculty · Dignity Health Methodist Hospital of Sacramento

Credentials: · · · ·

History

Subspecialty Education of Infectious Diseases Rotation · Bakersfield Memorial Hospital
Present
Dignity Health Methodist Hospital of Sacramento · St Joseph's Medical Center
Present

Infectious Disease
SUNY Downstate Health Sciences University
1994–1996
SUNY Downstate Health Sciences University
1991–1994
University of the Philippines College of Medicine, Manila
1987–1991

Research

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING…
The Lancet · 2013 · 459 citations
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
New England Journal of Medicine · 2018 · 334 citations
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label,…
The Lancet Infectious Diseases · 2017 · 280 citations

Fred Poordad
8 papers
HA
Humberto Aguilar
5 papers
MS
Mark Sulkowski
5 papers
ED
Edwin Dejesus
4 papers
Paul Kwo
4 papers
SW
Stanley Wang
4 papers
Tarek Hassanein
4 papers
MR
Moti Ramgopal
3 papers
RG
Reem Ghalib
3 papers
Stuart Gordon
3 papers
BM
Benedict Maliakkal
2 papers
CS
Catherine Small
2 papers

Clinical trials

Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
Principal investigator · Completed · Phase 4
Felizarta, Franco, M.D.
2009–2010
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Site PI · Recruiting · Phase 3
ViiV Healthcare
2026–2029
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Site PI · Recruiting · Phase 2
ViiV Healthcare
2026–2028